NanoCellect Biomedical

NanoCellect Biomedical is a private company providing innovative microfluidic cell sorting platforms that address the need for gentle, user-friendly, and compact instrumentation in life sciences. Founded in 2009 as a spinout from UCSD, its core technology leverages disposable microfluidic cartridges to sort cells at very low pressure, ensuring high viability and clonal outgrowth for sensitive applications. Backed by investors including Illumina Ventures and Agilent Technologies, the company targets the growing markets in cell therapy development, single-cell genomics, and antibody discovery with its WOLF and VERLO sorter families.

Gentle, low-pressure microfluidic cell sorting using disposable cartridges. Enables high-viability sorting and single-cell deposition of fragile cells with minimal shear stress and sterile, aerosol-free operation.

NanoCellect competes directly with high-pressure droplet cell sorters from BD Biosciences, Beckman Coulter, and Sony. It also faces competition from other gentle sorting technologies, such as acoustic-based sorters (e.g., Cytonome) and microfluidic/micro-well platforms from companies like Berkeley Lights (now part of Berkeley Lights) and Cell Microsystems. Its key differentiation is the combination of gentle microfluidics, sterility, and a compact, user-friendly design.